S
Stefania Dispinseri
Researcher at Vita-Salute San Raffaele University
Publications - 22
Citations - 581
Stefania Dispinseri is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Antibody & Medicine. The author has an hindex of 8, co-authored 16 publications receiving 320 citations. Previous affiliations of Stefania Dispinseri include University of Milan.
Papers
More filters
Journal ArticleDOI
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
Stefania Dispinseri,Massimiliano Secchi,Massimiliano Secchi,Maria Franca Pirillo,Monica Tolazzi,Martina Borghi,Cristina Brigatti,Maria Laura De Angelis,Marco Baratella,Elena Bazzigaluppi,Giulietta Venturi,Francesca Sironi,Andrea Canitano,Ilaria Marzinotto,Cristina Tresoldi,Fabio Ciceri,Lorenzo Piemonti,Donatella R.M. Negri,Andrea Cara,Vito Lampasona,Gabriella Scarlatti +20 more
TL;DR: In this article, the authors show that compromised immune responses to SARS-CoV-2 spike protein correlate with neutralizing capacity and protection, are not affected by heterologous boosting of influenza or common cold immunity, and can last up to 8 months.
Journal ArticleDOI
International network for comparison of HIV neutralization assays: the NeutNet report.
Eva Maria Fenyö,Alan Heath,Stefania Dispinseri,Harvey Holmes,Paolo Lusso,Susan Zolla-Pazner,Helen Donners,Leo Heyndrickx,José Alcamí,Vera Bongertz,Christian Jassoy,Mauro S. Malnati,David C. Montefiori,Christiane Moog,Lynn Morris,Saladin Osmanov,Victoria R. Polonis,Quentin J. Sattentau,Hanneke Schuitemaker,Ruengpung Sutthent,Terri Wrin,Gabriella Scarlatti +21 more
TL;DR: Clear differences in assay sensitivities were demonstrated that were dependent on both the neutralizing reagent and the virus, suggesting parallel use of PSV and VIA for vaccine evaluation.
Journal ArticleDOI
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.
Bin Su,Stefania Dispinseri,Valeria Iannone,Tong Zhang,Hao Wu,Raphael Carapito,Seiamak Bahram,Gabriella Scarlatti,Christiane Moog +8 more
TL;DR: The decreased risk of infection observed in the RV144 HIV-1 vaccine trial was correlated with the production of non-neutralizing inhibitory Abs, highlighting the role of Ab inhibitory functions besides neutralization.
Journal ArticleDOI
Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC)
Paolo Palma,Maria Luisa Romiti,Carla Montesano,Veronica Santilli,Nadia Mora,Angela Aquilani,Stefania Dispinseri,Hyppolite K. Tchidjou,Marco Montano,Lars E. Eriksson,Lars E. Eriksson,Stefania Baldassari,Stefania Bernardi,Gabriella Scarlatti,Britta Wahren,Paolo Rossi,Paolo Rossi +16 more
TL;DR: The present study demonstrates the feasibility, safety and moderate immunogenicity of genetic vaccination in vertically HIV-infected children, paving the way for amplified immunotherapeutic approaches in the pediatric population.
Journal ArticleDOI
Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia.
Stefania Dispinseri,Vito Lampasona,Massimiliano Secchi,Andrea Cara,Elena Bazzigaluppi,Donatella R.M. Negri,Cristina Brigatti,Maria Franca Pirillo,Ilaria Marzinotto,Martina Borghi,Patrizia Rovere-Querini,Cristina Tresoldi,Fabio Ciceri,Marina Scavini,Gabriella Scarlatti,Lorenzo Piemonti +15 more
TL;DR: In this paper, the authors characterized the kinetics and durability of neutralizing antibody (Nab) response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the presence of hyperglycemia.